Reducing endothelial NOS activation and interstitial fluid pressure with n –3 PUFA offset tumor chemoresistance

Archive ouverte

Kornfeld, Sophie | Goupille, Caroline | Vibet, Sophie | Chevalier, Stephan | Pinet, Amandine | Lebeau, Justine | Tranquart, François | Bougnoux, Philippe | Martel, Eric | Maurin, Anne | Richard, Serge | Champeroux, Pascal | Mahéo, Karine

Edité par CCSD ; Oxford University Press -

International audience. The aim of this study was to determine how n-3 polyunsaturated fatty acid (PUFAs) counteracted tumor chemoresistance by restoring a functional vascularization. Rats with chemically induced mammary tumors were divided into two nutritional groups: a control group and a group fed with an n-3 PUFA-enriched diet. Both groups were treated with docetaxel. Functional vascular parameters (ultrasounds, interstitial fluid pressure) were determined for both nutritional groups before (W(0)) and during docetaxel treatment [every 2 h up to 1 week (W(+1)) for interstitial fluid pressure, at W(+1) for Evans blue extravasation and at W(+2) and W(+6) for ultrasounds]. In vitro n-3 PUFA-induced changes in endothelial cell migration, permeability and phosphorylation of endothelial nitric oxide synthase were evaluated using human umbilical vein endothelial cells. Whereas docetaxel stabilized tumor growth in the rat control group, it induced a 50% tumor regression in the n-3 PUFA group. Ultrasounds parameters were consistently lower in the n-3 PUFA group at all time points measured, down to ∼50% at W(+6). A single dose of docetaxel in the n-3 PUFA group markedly reduced interstitial fluid pressure from 2 h after injection up to W(+1) when Evans blue extravasation was increased by 3-fold. A decreased activation of endothelial nitric oxide synthase in tumors of the n-3 PUFA group, and in human umbilical vein endothelial cell cultured with n-3 PUFA, points toward a PUFA-induced disruption of nitric oxide signaling pathway. This normalization of tumor vasculature functions under n-3 PUFA diet indicates that such a supplementation, by improving drug delivery in mammary tumors, could be a complementary clinical strategy to decrease anticancer drug resistance.

Consulter en ligne

Suggestions

Du même auteur

Non-invasive quantification of tumor vascular architecture during docetaxel-chemotherapy

Archive ouverte | Mahéo, Karine | CCSD

International audience. New ultrasound parameters, potentially predictive of tumor response to chemotherapy, were sought after analyzing details of vascular architecture of mammary tumors during chemotherapy. Tumor-...

Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization.

Archive ouverte | Colas, Séverine | CCSD

PURPOSE: To investigate whether dietary docosahexaenoic acid (DHA), a peroxidizable polyunsaturated omega-3 fatty acids, sensitizes rat mammary tumors to anthracyclines and whether its action interferes with tumor vascularization,...

A step towards characterisation of electrophysiological profile of torsadogenic drugs

Archive ouverte | Champeroux, Pascal | CCSD

International audience

Chargement des enrichissements...